Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.220
-0.050 (-3.94%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Marker Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.2 | 3.55 | 6.59 | 3.31 | 9.01 | 1.24 | |
Revenue Growth (YoY) | -43.86% | -46.19% | 99.06% | -63.27% | 625.90% | 166.01% |
Gross Profit | 3.2 | 3.55 | 6.59 | 3.31 | 9.01 | 1.24 |
Selling, General & Admin | 4.05 | 4.18 | 4.24 | 7.48 | 12.82 | 12.92 |
Research & Development | 11.51 | 11.8 | 13.47 | 10.42 | 26.14 | 27.79 |
Other Operating Expenses | - | 0.45 | - | - | - | - |
Total Operating Expenses | 15.55 | 16.44 | 17.71 | 17.89 | 38.96 | 40.72 |
Operating Income | -12.35 | -12.89 | -11.12 | -14.58 | -29.95 | -39.48 |
Interest Income | 0.56 | 0.59 | 0.44 | 0.54 | 0.25 | 0.01 |
Other Non-Operating Income (Expense) | 0.13 | 0.12 | - | - | -0.23 | -2.41 |
Total Non-Operating Income (Expense) | 0.69 | 0.71 | 0.44 | 0.54 | 0.02 | -2.4 |
Pretax Income | -11.66 | -12.18 | -10.68 | -14.04 | -29.93 | -41.88 |
Provision for Income Taxes | - | -0.02 | 0.05 | 0 | - | - |
Net Income | -11.66 | -12.16 | -10.73 | -14.05 | -29.93 | -41.88 |
Earnings From Discontinued Operations | - | - | - | 11.62 | - | - |
Net Income to Common | -10.9 | -12.16 | -10.73 | -8.24 | -29.93 | -41.88 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 15 | 9 | 9 | 8 | 8 |
Shares Outstanding (Diluted) | 17 | 15 | 9 | 9 | 8 | 8 |
Shares Change (YoY) | 82.00% | 70.49% | 1.94% | 5.49% | 9.16% | 62.64% |
EPS (Basic) | -0.61 | -0.79 | -1.19 | -0.94 | -3.58 | -5.47 |
EPS (Diluted) | -0.61 | -0.79 | -1.19 | -0.94 | -3.58 | -5.47 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -7.92 | -12.01 | -10.91 | -16.44 | -31.92 | -30.41 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.46 | -0.78 | -1.21 | -1.87 | -3.82 | -3.97 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -386.37% | -363.45% | -168.69% | -440.37% | -332.23% | -3179.32% |
Profit Margin | -364.76% | -342.96% | -162.82% | -424.20% | -332.06% | -3372.68% |
FCF Margin | -247.64% | -338.74% | -165.53% | -496.51% | -354.10% | -2449.11% |
EBITDA | -12.35 | -12.89 | -11.12 | -14.58 | -26.27 | -36.32 |
EBITDA Margin | -386.37% | -363.45% | -168.69% | -440.37% | -291.40% | -2924.62% |
EBIT | -12.35 | -12.89 | -11.12 | -14.58 | -29.95 | -39.48 |
EBIT Margin | -386.37% | -363.45% | -168.69% | -440.37% | -332.23% | -3179.32% |
Effective Tax Rate | - | 0.12% | -0.47% | -0.03% | 0.00% | 0.00% |